Ralph W. Aye, MD, Program Leader, Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA, shares his thoughts on the cost of lung cancer screening. Sponsored by The Doctor’s…
According to results of a multicenter randomized clinical trial, patients with advanced NSCLC derived no benefit from the addition of sorafenib (Nexavar) to chemotherapy. References and Resources Scagliotti…
In a phase III, randomized, open-labeled, noninferiority study that compared clinical cure of ventilator-associated pneumonia with doripenem IV with two different does of imipenem IV, length of stay…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses his thoughts on…
Howard (Jack) West, MD, Medical Director, Thoracic Oncology Program Swedish Cancer Institute, President & CEO, Global Resource for Advancing Cancer Education (GRACE), Seattle, WA, discusses lung cancer in…
The FDA has posted a warning alerting clinicians of pooled data from 29 placebo-controlled trials of tiotropium that revealed excess strokes among COPD patients on active treatment. References…
A recent study demonstrates that in patients with very mild or well-controlled asthma, regular treatment with low dose ICS leads to significantly better day-to-day lung function. References and…
Exercising one leg at a time can improve aerobic capacity more than two-legged exercise in patients with stable chronic obstructive pulmonary disease (COPD), according to a report in…
Friedrich Kueppers, MD, Professor of Medicine and Immunology, Temple University School of Medicine, discusses screening for COPD. References and Resources Hemminki K, Li X, Sundquist K, Sundquist J.…
Francis Cordova, MD, Medical Director, Lung Transplantation Program, Temple University School of Medicine, discusses when to refer patients for transplantation. References and Resources Goldberg HJ, Deykin A. Advances…